Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia

Ulotaront (SEP‐363856) is a trace amine–associated receptor 1 agonist with 5‐HT(1A) agonist activity in phase III development for the treatment of schizophrenia. The efficacy of ulotaront is not mediated by blockade of D(2) or 5‐HT(2A) receptors. The aim of this study was to evaluate the population...

Descripción completa

Detalles Bibliográficos
Autores principales: Galluppi, Gerald R., Polhamus, Daniel G., Fisher, Jeannine M., Hopkins, Seth C., Koblan, Kenneth S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520744/
https://www.ncbi.nlm.nih.gov/pubmed/34292664
http://dx.doi.org/10.1002/psp4.12692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520744/
https://www.ncbi.nlm.nih.gov/pubmed/34292664
http://dx.doi.org/10.1002/psp4.12692

Ejemplares similares